NEW YORK (TheStreet) -- RATINGS CHANGES
Alamos Gold (AGI) was ihttp://dps.thestreet.com/rosebud/ui/story/editor.do?id=12684513nitiated with a sell rating at TheStreet Ratings.
Antero (AR) was reinitiated at UBS with a buy rating. Production in-line, but gas pricing after hedging was stronger than forecast, UBS said. Twelve-month price target is $75.
Autodesk (ADSK) was upgraded at Pacific Crest to neutral from sector perform. Twelve-month price target is $60. Channels suggest suggest ongoing business improvement, Pacific Crest said.
Allergan (AGN) was downgraded at Stifel Nicolaus to hold from buy. Valuation call, as the stock is up 50% year to date, Stifel Nicolaus said.
TD Ameritrade (AMTD) was upgraded at Bernstein to outperform from market perform. Twelve-month price target is $40. Company is leveraged to the retail investors' return to the market, Bernstein said.
BlackBerry (BBRY) was upgraded at Oppenheimer to perform from underperform. Valuation call, based on a sum-of-the-parts valuation, Oppenheimer said.
Centurylink (CTL) was downgraded at BMO Capital to market perform. Valuation call, based on a 12-month price target of $33, BMO Capital said.
Deckers (DECK) was upgraded at Credit Suisse to neutral from underperform. Twelve-month price target is $82. Company is seeing better international and retail growth, Credit Suisse said.
Dreamworks (DWA) was downgraded at Bank of America/Merrill Lynch to underperform. Twelve-month price target is $22. Estimates were also cut, given poor box office performance of Peabody movie, Bank of America/Merrill Lynch said.
Hornbeck Offshore (HOS) was upgraded at Wunderlich to buy from hold. Twelve-month price target is $55. Estimates were also increased, as new rig deliveries should drive demand in the Gulf of Mexico, Wunderlich said.
Masco (MAS) was upgraded at Citigroup to buy. Guidance is better than the market is giving the company credit for, Citigroup said.
Mattress Firm (MFRM) was downgraded at Keybanc to hold from buy. Valuation call, as the company has near-term earnings risks, Keybanc said.
Meritage (MTH) was upgraded at UBS to neutral from sell. Valuation call with 12-month price target of $39, UBS said.
Ritchie (RBA) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $29. Company has multiple potential catalysts, Robert Baird said.